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Outpatient treatment for neonates and young infants with 
clinically suspected severe infection
The reduction in mortality in children younger than 
5 years over recent decades has been impressive, 
but shortfalls still exist in achievement of the MDG4 
targets.1 Acceleration of progress for child survival would 
need increased emphasis on quality care at and around 
birth, and timely and eﬃ  cacious treatment for neonatal 
infections, diarrhoea, and pneumonia in regions where 
these causes contribute substantially to mortality in 
children younger than 5 years. The challenge in provision 
of standard care is increased wherever health systems 
are weak, socioeconomic conditions are suboptimum, 
and settings are remote and inaccessible. Innovative 
implementation research is being widely promoted to 
provide solutions that improve equitable delivery of 
established interventions without compromising safety 
or eﬀ ectiveness. This type of research is challenging and 
often complex.
In The Lancet Global Health, Abdullah Baqui and 
colleagues2 report their ﬁ ndings from a large 
equivalence trial in Bangladesh, in which two antibiotic 
regimens were compared with the standard regimen 
(intramuscular injections of procaine benzylpenicillin 
and gentamicin once per day for 7 days) for treatment 
of clinically suspected serious infection in young infants 
(aged 0–59 days) who were treated in an outpatient 
setting after their parents sought help but refused 
hospital admission.
The two alternative regimens assessed were: intra-
muscular gentamicin once per day and oral amoxicillin 
twice per day for 7 days; and intramuscular procaine 
benzylpenicillin and intramuscular gentamicin once per 
day for 2 days, followed by oral amoxicillin twice per 
day for 5 days. Thus, compared with the 14 injections 
in the reference treatment, these regimens had reduced 
numbers of injections (seven and four, respectively). The 
primary outcome was a composite measure of treatment 
failure by day 8 of enrolment based on several individual 
indicators, and deaths were also carefully recorded. 
The risk of treatment failure was 8% in each of the 
two alternative regimens, compared with 10% in 
the standard treatment group.2 Risk of death by day 
15 of follow-up was 2% in all treatment groups. This 
result was similar to the number of deaths in infants 
who opted for hospital admission (2% in hospital and 
another 1% within one week of discharge). We believe 
that the equivalence of these regimens for the primary 
outcome was satisfactorily established in the type of 
patients enrolled. The case fatality rates were low overall 
and consistent with the similar failure rates across 
treatment arms. 
What are the implications of these ﬁ ndings for child 
health programmes? In an ideal world, serious infections 
in neonates and young infants would be treated in 
medical facilities. However, the barriers to such care are 
overwhelming for millions of families in Asia and Africa. 
Facilities can be far away, often the services provided are 
of poor quality, and families might not be able to aﬀ ord 
the related direct and indirect costs of care. Therefore, 
simpliﬁ ed outpatient treatment regimens in settings 
close to home make for a strong programmatic rationale 
for treatment of serious infections in young infants 
whose caregivers are unwilling or unable to accept 
hospital admission. Widespread acceptance of such a 
strategy needs rigorous and conclusive evidence for its 
feasibility, eﬃ  cacy, and safety. In this respect, Baqui and 
colleagues should be complimented for designing and 
undertaking a high quality study that paves the way for 
adoption of this approach in health programmes. 
Some limitations of the study, however, should be 
noted. The trial was not masked for practical reasons. 
The trial enrolled fewer infants younger than 7 days than 
older infants, and this subgroup might diﬀ er in terms of 
causes and outcomes. The study individuals were young 
infants whose families sought care but did not accept 
admission to hospital; the infants in the study might 
therefore represent a group with milder disease than 
that of those who accepted hospital admission. 
In this eﬃ  cacy trial, high compliance was achieved for 
all regimens, which were delivered at home through 
regular physician visits. Regardless of the regimen, 
compliance with treatment and monitoring might be 
better in hospitals than at home in real-life programmes. 
Our view is that referral and hospital admission should 
be promoted for sick neonates and young infants. The 
study results do, however, provide good evidence that 
when hospital admission is not feasible, and if simpliﬁ ed 
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regimens can be delivered in outpatient settings, 
complications rates would be low and similar to those 
in hospitals. 
Community-based management of infections in 
young infants that includes intramuscular injections 
every day for 7 or more days, given by trained health 
workers, has been studied and reported to be eﬀ ective.3–5 
Regimens with reduced numbers of injections could 
be easier to deliver and have a substantial eﬀ ect on 
young infant mortality. However, in many countries or 
subregions, even these simpliﬁ ed regimens might be 
challenging. The questions of who should give injections 
in primary care and outpatient settings, and at what 
level in the health-care system, remain unsettled in 
many developing countries.
Growing realisation exists that primary health centres 
need to be upgraded to become eﬀ ective treatment 
facilities. The health-care providers deployed to them 
should be able to assess young infants whose parents 
seek care, arrange referral for hospital admission for 
those with possible serious infections, and when 
that is not acceptable to the families, they could 
oﬀ er ambulatory treatment using one of the study 
regimens in Baqui and colleagues’ study.2 The treatment 
provider could be a doctor (as in the study, but often 
not feasible), or an eﬀ ectively trained health assistant, 
nurse, or auxiliary nurse midwife. This approach could 
particularly help female infants whose care-seeking 
is diﬀ erentially undermined in many societies. For 
outpatient treatment to be eﬀ ective, frontline 
treatment centres need to be predictably open and 
accessible to families, and have adequate supplies. The 
interface between home and the treating health centre, 
and between the treatment provider and the hospital 
doctor, will need to be optimised and supported. Safety 
margins in care can be enhanced further through mobile 
phone communication wherever possible. 
Overall, the innovative ﬁ ndings of the trial2 are a 
valuable contribution, and a vital part of a whole 
solution in which other components must fall into place 
to have a noticeable eﬀ ect on mortality in neonates and 
young infants. Studies such as these should motivate 
reﬂ ection and action. 
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